Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Metabolic Dysfunction-Associated Liver Diseases
Questions discussed in this category
How do you approach a patient's candidacy for simultaneous liver transplant and bariatric surgery if MASLD is the etiology of their end-stage liver disease?
1 Answer available
What is your approach on the pursuit of bariatric surgery in a patient with advanced fibrosis?
1 Answer available
If you do not have easy access to shear wave elastography (aka Fibroscan), what do you recommend for non-invasive tests to determine if a MASLD patient has clinically significant portal hypertension and risk-stratify them?
1 Answer available
How does presence of clinically significant portal hypertension change patient prognosis in MASLD?
1 Answer available
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
1 Answer available
How do you approach an obese patient on long-term methotrexate with normal liver tests in terms of workup for underlying fatty liver?
Would you start with a baseline ultrasound and then pursue further workup such as fibroscan if fatty liver is present, or other?
1 Answer available
23704
23702
24248
23703
22838
18122
Papers discussed in this category
International journal of molecular sciences, 2022 Mar 13
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection.
Related Topics
Hepatology
Gastroenterology
General Hepatology
Primary Care
Endocrinology
Rheumatology
Rheumatoid Arthritis
Diabetes
Obesity Medicine
General Gastroenterology